Salim Syed
Stock Analyst at Mizuho
(4.06)
Main Sectors:
Top Industries:
14 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NKTX Nkarta | Maintains: Outperform | 16 14 | 2.13 | 557.28% | 8 | Jun 10, 2025 | |
CYTK Cytokinetics | Maintains: Outperform | 103 84 | 56.97 | 47.45% | 7 | May 29, 2025 | |
BIIB Biogen | Maintains: Outperform | 207 169 | 159.88 | 5.7% | 16 | May 7, 2025 | |
AMGN Amgen | Maintains: Neutral | 235 280 | 297.89 | -6.01% | 8 | May 7, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 100 117 | 112.69 | 3.82% | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 22 | 7.15 | 207.69% | 5 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 113 163 | 42.66 | 282.09% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 25 18 | 14.41 | 24.91% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | 19.61 | 73.38% | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 82 99 | 67.74 | 46.15% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 53 | 52.86 | 0.26% | 7 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | n/a | n/a | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 1.64 | 1180.49% | 5 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 168 36 | 23.32 | 54.37% | 1 | Nov 16, 2022 |